Peptide record

TPDB05896

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05896
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia SATPdb dbACP CAFPdb dbAMP 3.0 ToxinPred 3.0
standard
No
A 9-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SVAGRAQGM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C34H61N13O12S1
NDCEHILKFPTWY
AG
876.00
11.05
1
0
4
+1
1.33
0.011
54.44
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
0
E
1
Q
2
G
0
H
0
I
0
L
0
K
1
M
0
F
0
P
1
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 2 H: 0 I: 0 L: 0 K: 0 M: 1 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
9 reviewed residue count
C34H61N13O12S1 sequence-only estimate (linear, free termini)
876.00 sequence-only estimate (linear, free termini)
11.05 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
1.33 sequence-only estimate (linear, free termini)
0.011 sequence-only estimate (linear, free termini)
Evidence Records 8 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Weakly active against E. coli, B. subtilis, P. aeruginosa, and S. aureus (MIC ~ 80 ug/ml). The antibacterial activity of this series of peptides is Cn-AMP1 > Cn-AMP2 > Cn-AMP3. Cn-AMP1 also displayed antifungal, anticancer, and immune modulating activity ( Silva et al. 2012 ).
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Weakly active against E. coli, B. subtilis, P. aeruginosa, and S. aureus (MIC ~ 80 ug/ml). The antibacterial activity of this series of peptides is Cn-AMP1 > Cn-AMP2 > Cn-AMP3. Cn-AMP1 also displayed antifungal, anticancer, and immune modulating activity ( Silva et al. 2012 ).
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
dbAMP 3.0 classified under the Anti-parasitic function class.
Weakly active against E. coli, B. subtilis, P. aeruginosa, and S. aureus (MIC ~ 80 ug/ml). The antibacterial activity of this series of peptides is Cn-AMP1 > Cn-AMP2 > Cn-AMP3. Cn-AMP1 also displayed antifungal, anticancer, and immune modulating activity ( Silva et al. 2012 ).
Evidence 4 Activity

Activity

Antiviral

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiviral
dbAMP 3.0 classified under the Anti-viral function class.
Weakly active against E. coli, B. subtilis, P. aeruginosa, and S. aureus (MIC ~ 80 ug/ml). The antibacterial activity of this series of peptides is Cn-AMP1 > Cn-AMP2 > Cn-AMP3. Cn-AMP1 also displayed antifungal, anticancer, and immune modulating activity ( Silva et al. 2012 ).
Evidence 5 Activity

Activity

0±0.4% Hemolysis
Toxicity
375 µM
Hemolytic Cytotoxic
0±0.4% Hemolysis | 375 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases. | Peptides | 2018
Evidence 6 Activity

Activity

7.7±3.93% Hemolysis
Toxicity
400 µM
Hemolytic Cytotoxic
7.7±3.93% Hemolysis | 400 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Cn-AMP1: a new promiscuous peptide with potential for microbial infections treatment. | Biopolymers | 2012
Evidence 7 Activity

Activity

0% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
0% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Cn-AMP1: a new promiscuous peptide with potential for microbial infections treatment. | Biopolymers | 2012
Evidence 8 Activity

Activity

50% Cell death
Toxicity
>500 µg/mL
Cytotoxic
50% Cell death | >500 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus | Biopolymers | 2017